1887

Abstract

By using a retrovirus expression vector, pZIP-NeoSV(X)1, we introduced a cloned cDNA of the rabies virus G gene into BHK-21 cells and the NA cell clone originated from the murine neuroblastoma C1300 line. Using the neomycin resistance gene of the vector, we isolated several G418-resistant transformants of BHK-21 and NA cells (referred to as G-BHK and G-NA cells, respectively). G-BHK cells constitutively produced G proteins, whereas G-NA cells produced the proteins only when treated with sodium butyrate. G proteins synthesized in these transformants were transported normally to the surface of the cell, but they displayed different electrophoretic mobilities, which were shown to originate from differences in the number and structure of the carbohydrate moieties of the protein; G-BHK cells produced highly glycosylated and sialylated G proteins, whereas less glycosylated and much less sialylated G proteins were produced by G-NA cells as observed in virus-infected NA and BHK-21 cells, indicating that the glycosylation and sialylation of the G protein depend on the cellular conditions under which the protein was produced. In the absence of sodium butyrate the G protein was not detectable in G-NA cells either by immunoblot assay or fluorescent antibody staining, but the cells were fairly sensitive to syngeneic rabies virus-specific cytotoxic T lymphocytes, although the sensitivity was much increased by treatment with sodium butyrate.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-2-335
1992-02-01
2022-01-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/2/JV0730020335.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-2-335&mimeType=html&fmt=ahah

References

  1. Anilionis A., Wunner W. H., Curtis P. J. 1981; Structure of the glycoprotein gene in rabies virus. Nature, London 294:275–278
    [Google Scholar]
  2. Bohan C., York D., Srinivasan A. 1987; Sodium butyrate activates human immunodeficiency virus long terminal repeat directed expression. Biochemical and Biophysical Research Communications 148:899–905
    [Google Scholar]
  3. Celis E., Rupprecht C. E., Plotkin S. A. 1990; New and improved vaccines against rabies. In New Generation Vaccines pp 419–438 Edited by Woodrow G. C., Levine M. M. New York: Marcel Dekker;
    [Google Scholar]
  4. Cepko C. L., Roberts B. E., Mulligan R. C. 1984; Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37:1053–1062
    [Google Scholar]
  5. Chamberlain J. P. 1979; Fluorographic detection of radioactivity in polyacrylamide gels with the water–soluble fluor, sodium salicylate. Analytical Biochemistry 98:132–135
    [Google Scholar]
  6. Cho S., Narahara H., Mifune K., Kawai A. 1987; Murine T cell clones directed to rabies virus: isolation and some of their properties. Journal of General Virology 68:1115–1123
    [Google Scholar]
  7. Cox J. H., Dietzschold B., Schneider L. G. 1977; Rabies virus glycoprotein. II. Biological and serological characterization. Infection and Immunity 16:754–759
    [Google Scholar]
  8. Davis L. G., Dibner M. D., Battey J. F. 1986 Methods in Molecular Biology New York: Elsevier;
    [Google Scholar]
  9. Dietzschold B. 1977; Oligosaccharides of the glycoprotein of rabies virus. Journal of Virology 23:286–293
    [Google Scholar]
  10. Dietzschold B., Wunner W. H., Wiktor T. J., Lopes A. D., Lafon M., Smith C. L., Koprowski H. 1983; Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences, U.S.A 80:70–74
    [Google Scholar]
  11. Etchison J. R., Holland J. J. 1974; Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus grown in four mammalian cell lines. Proceedings of the National Academy of Sciences, U.S.A 71:4011–4014
    [Google Scholar]
  12. Gorman C. M., Howard B. H. 1983; Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Research 11:7631–7648
    [Google Scholar]
  13. Hawkes R., Niday E., Gordon J. 1982; A dot immunobinding assay for monoclonal and other antibodies. Analytical Biochemistry 119:142–147
    [Google Scholar]
  14. Hilberg F., Stocking C., Ostertag W., Grez M. 1987; Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proceedings of the National Academy of Sciences, U.S.A. 84:5232–5236
    [Google Scholar]
  15. Hsieh P., Rosner M. R., Robbins P. W. 1983; Host-dependent variation of asparagine-linked oligosaccharides at individual glycosylation sites of Sindbis virus glycoproteins. Journal of Biological Chemistry 258:2548–2554
    [Google Scholar]
  16. Kawai A., Matsumoto S. 1981; Production of spikeless particles of the rabies virus under conditions of low pH. Virology 108:267–276
    [Google Scholar]
  17. Kawai A., Matsumoto S. 1982; A sensitive bioassay system for detecting defective interfering particles of rabies virus. Virology 122:98–108
    [Google Scholar]
  18. Kawai A., Matsumoto S., Tanabe K. 1975; Characterization of rabies viruses recovered from persistently infected BHK cells. Virology 63:520–533
    [Google Scholar]
  19. Kawano H., Mifune K., Ohuchi M., Mannen K., Cho S., Hiramatsu K., Shichijo A. 1990; Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. Journal of General Virology 71:281–287
    [Google Scholar]
  20. Kieny M. P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T. J., Koprowski H., Lecocq J. P. 1984; Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature, London 312:163–166
    [Google Scholar]
  21. Kyhse-Andersen J. 1984; Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. Journal of Biochemical and Biophysical Methods 10:203–209
    [Google Scholar]
  22. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  23. Lopata M. A., Cleveland D. W., Sollner-Webb B. 1984; High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran-mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. Nucleic Acids Research 12:5707–5717
    [Google Scholar]
  24. MacFarlan R. I., Dietzschold B., Wiktor T. J., Kiel M., Houghten R., Lerner R. A., Sutcliffe J. G., Koprowski H. 1984; T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. Journal of Immunology 133:2748–2752
    [Google Scholar]
  25. Machamer C. E., Rose J. K. 1988a; Influence of new glycosylation sites on expression of the vesicular stomatitis virus G protein at the plasma membrane. Journal of Biological Chemistry 263:5948–5954
    [Google Scholar]
  26. Machamer C. E., Rose J. K. 1988a; Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature sensitive intracellular transport and are subject to aberrant inter– molecular disulfide bonding. Journal of Biological Chemistry 263:5955–5960
    [Google Scholar]
  27. Maniatis T., Frisch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Mannual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  28. Morimoto K., Ohkubo A., Kawai A. 1989; Structure and transcription of the glycoprotein gene of attenuated HEP–Flury strain of rabies virus. Virology 173:465–477
    [Google Scholar]
  29. Naito S., Matsumoto S. 1978; Identification of cellular actin within the rabies virus. Virology 91:151–163
    [Google Scholar]
  30. Prehaud C., Coulon P., Lafay F., Thiers C., Flamand A. 1988; Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. Journal of Virology 62:1–7
    [Google Scholar]
  31. Prehaud C., Takehara K., Flamand A., Bishop D. H. L. 1989; Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 173:390–399
    [Google Scholar]
  32. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  33. Puddington L., Woodgett C., Rose J. K. 1987; Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells. Proceedings of the National Academy of Sciences, U.S.A 84:2756–2760
    [Google Scholar]
  34. Robertson J. S., Etchison J. R., Summers D. F. 1976; Glycosylation sites of vesicular stomatitis virus glycoprotein. Journal of Virology 19:871–878
    [Google Scholar]
  35. Romero P. A., Datema R., Schwarz R. T. 1983; N-Methyl-1-deoxynojirimycin, a novel inhibitor of glycoprotein processing, and its effect on fowl plague virus maturation. Virology 130:238–242
    [Google Scholar]
  36. Rott R., Orlich M., Klenk H. D., Wang M. L., Skehel J. J., Wiley D. C. 1984; Studies on the adaptation of influenza viruses to MDCK cells. EMBO Journal 3:3329–3332
    [Google Scholar]
  37. Rupprecht C. E., Wiktor T. J., Johnston D. H., Hamir A. N., Dietzschold B., Wunner W. H., Glickman L. T., Koprowski H. 1986; Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia rabies glycoprotein recombinant virus vaccine. Proceedings of the National Academy of Sciences, U.S.A. 83:7947–7950
    [Google Scholar]
  38. Schneider F. H. 1976; Effect of sodium butyrate on mouse neuroblastoma cells in culture. Biochemical Pharmacology 25:2309–2317
    [Google Scholar]
  39. Seif L., Coulon P., Rollin P. E., Flamand A. 1985; Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. Journal of Virology 53:926–934
    [Google Scholar]
  40. Takatsuki A., Kohno K., Tamura G. 1975; Inhibition of biosynthesis of polyisoprenol sugars in chick embryo microsomes by tunicamycin. Agricultural and Biological Chemistry 39:2089–2091
    [Google Scholar]
  41. Tordo N., Poch O., Ermine A., Keith G., Rougeon F. 1986; Walking along the rabies genome: is the large G-L intergenic region a remnant gene?. Proceedings of the National Academy of Sciences, U,. S,. A 83:3914–3918
    [Google Scholar]
  42. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
  43. Wiktor T. J., Gyorgy E., Schlumberger H. D., Sokol F., Koprowski H. 1973; Antigenic properties of rabies virus components. Journal of Immunology 110:269–276
    [Google Scholar]
  44. Wunner W. H., Dietzschold B., Smith C. L., Lafon M., Golub E. 1985; Antigenic variants of CVS rabies virus with altered glycosylation sites. Virology 140:1–12
    [Google Scholar]
  45. Yelverton E., Norton S., Obiieski J. F., Goeddel D. V. 1983; Rabies virus glycoprotein analogs:. biosynthesis in Escherichia coli. Science 219614–620
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-2-335
Loading
/content/journal/jgv/10.1099/0022-1317-73-2-335
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error